Table 1. Demographic and clinical characteristics of the study population.
Age (years) | 65.3 ± 14.9 |
Dry weight (Kg) | 66.1 ± 12.2 |
Dialysis vintage (years) | 4.3 ± 4.3 |
Males (%) | 51.5 |
Kt / v urea | 1.47 ± 0.3 |
*Vitamin D therapy (%) | 55.9 |
Cinacalcet (%) | 19.1 |
Calcium-based phosphate binders (%) | 42.6 |
Sevelamer (%) | 36.7 |
*25OH vitamin D, calcitriol or paricalcitol.